The REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey in Europe: Country-specific comparisons of postmenopausal women's perceptions, experiences and needs

被引:44
作者
Nappi, Rossella E. [1 ]
Palacios, Santiago [2 ]
Particco, Martire [3 ]
Panay, Nick [4 ]
机构
[1] Univ Pavia, IRCCS S Matteo Fdn, Res Ctr Reprod Med Gynecol Endocrinol & Menopause, Dept Clin Surg Diagnost & Paediat Sci, Pavia, Italy
[2] Palacios Inst Womens Hlth, Madrid, Spain
[3] Shionogi Italy, Rome, Italy
[4] Imperial Coll London, London, England
关键词
Vulvar and vaginal atrophy; Postmenopausal women; REVIVE survey; Europe; Sexual relationships; Vaginal dryness; Dyspareunia; Treatment; GENITOURINARY SYNDROME; ESTROGEN THERAPY; SEXUAL HEALTH; ATROPHY; IMPACT; MANAGEMENT; ATTITUDES; SYMPTOMS; VULVAR;
D O I
10.1016/j.maturitas.2016.06.010
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objectives: To achieve a better comprehension of the variability of perceptions, experiences and needs in terms of sexual and vaginal health in postmenopausal women (PMW) from four different European countries. Methods: An internet-based survey was conducted in Italy, Germany, Spain and the United Kingdom with a total surveyed population of 3768 PMW aged between 45 and 75 years. Results: The UK sample was significantly older, with almost a quarter of participants over 65 years of age, and had the highest proportion of women experiencing recent vulvar and vaginal atrophy (52.8%). The majority of Italian and Spanish participants were receiving WA treatment, whereas in the UK only 28% of PMW were on medication. The most common menopausal symptom was vaginalivulvar dryness, with almost 80% of participants reporting it in all the countries except the UK (48%). On the other hand, vaginalivulvar irritation was more frequently reported in the UK (41%). The percentage of participants with a partner was lower in the UK (71%), as was the monthly rate of sexual activity (49%). In the UK, the proportion of participants who had seen a healthcare professional for gynaecological reasons in the last year was lower than in other countries (27% vs.>= 50%), as was the proportion who has discussed their WA symptoms with them (45% vs. similar to 67%). In this sense, UK PMW waited for a longer before asking for help (especially for pain with intercourse and dryness). The main issues relating to WA treatment difficulties expressed by participants were administration route in the UK, efficacy in Germany, and side-effects in Italy. Conclusions: Although all European women shared the same expectation of improving the quality of their sex lives, the opportunity for that varied among different countries in relation to the healthcare system and to the effective communication achieved with healthcare professionals when managing WA. (C) 2016 Published by Elsevier Ireland Ltd.
引用
收藏
页码:81 / 90
页数:10
相关论文
共 29 条
[1]  
[Anonymous], 2012, 2011 EU CENS
[2]  
[Anonymous], 2009, REVEAL REvealing Vaginal Effects At mid-Life: Surveys of postmenopausal women and health care professionals who treat postmenopausal women
[3]   The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society [J].
Bachmann, Gloria A. ;
Johnston, Shawna L. ;
Kessel, Bruce ;
Knobf, M. Tish ;
Stewart, Elizabeth G. .
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2007, 14 (03) :357-371
[4]   Symptoms of the menopause [J].
Bruce, Deborah ;
Rymer, Janice .
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2009, 23 (01) :25-32
[5]   Characteristics of post-menopausal women with genitourinary syndrome of menopause: Implications for vulvovaginal atrophy diagnosis and treatment selection [J].
Castelo-Branco, Camil ;
Biglia, Nicoletta ;
Nappi, Rossella E. ;
Schwenkhagen, Anne ;
Palacios, Santiago .
MATURITAS, 2015, 81 (04) :462-469
[6]   European patients' views on the responsiveness of health systems and healthcare providers [J].
Coulter, A ;
Jenkinson, C .
EUROPEAN JOURNAL OF PUBLIC HEALTH, 2005, 15 (04) :355-360
[7]   Multinational Internet-based survey of patient preference for newer oral or injectable Type 2 diabetes medication [J].
DiBonaventura, Marco daCosta ;
Wagner, Jan-Samuel ;
Girman, Cynthia J. ;
Brodovicz, Kimberly ;
Zhang, Qiaoyi ;
Qiu, Ying ;
Pentakota, Sri-Ram ;
Radican, Larry .
PATIENT PREFERENCE AND ADHERENCE, 2010, 4 :397-406
[8]  
Domoney Claudine, 2013, Menopause Int, V19, P69, DOI 10.1177/1754045313484139
[9]   Vulvar and Vaginal Atrophy in Postmenopausal Women: Findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) Survey [J].
Kingsberg, Sheryl A. ;
Wysocki, Susan ;
Magnus, Leslie ;
Krychman, Michael L. .
JOURNAL OF SEXUAL MEDICINE, 2013, 10 (07) :1790-1799
[10]   Resistance and Barriers to Local Estrogen Therapy in Women with Atrophic Vaginitis [J].
Kingsberg, Sheryl A. ;
Krychman, Michael L. .
JOURNAL OF SEXUAL MEDICINE, 2013, 10 (06) :1567-1574